Live symbol workspace

WST market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Current $359.70

Trend Flat

Sentiment Neutral

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support

$341.71

Resistance

$377.69

Volume & Momentum

Volume

Weak

0.8x avg

Momentum

0%

Weak

Technical Context

Current price

$359.70

RSI context

50

Market Sentiment

50

Neutral

Stock Metrics

Daily Vol

0%

VIX Est

20

Weekly

0%

Asset Intelligence Dossier

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

30%

— 0.0 pts vs previous week

Avg confidence across 7 calls in the last 7 days

What sources say

Bullish 1 article

WST Stock Surges 38.1% Since March-End: What's Fueling the Rally?

Insider Trading

Refreshing insider trades from FinViz…

Technical Observations

Refreshing technical observations from FinViz...

WST News Intelligence (2 articles)

AI-curated news influencing WST price, sentiment, and trend

Explore All WST News with AI Analysis

Economy

2 weeks ago

WST Stock Surges 38.1% Since March-End: What's Fueling the Rally?

West Pharmaceutical Services has surged 38.1% since March-end as HVP demand, GLP-1 growth and productivity gains fuel the rally.

Impact on WST: Potentially positive price action expected

Analysis of stock market developments showing bullish sentiment. High (80%)

View full analysis →

Yahoo Finance 80% confidence

Economy

1 month, 2 weeks ago

3 Reasons WST is Risky and 1 Stock to Buy Instead

Over the past six months, West Pharmaceutical Services has been a great trade, beating the S&P 500 by 21.8%. Its …

Impact on WST: The recent surge in WST's stock price may lead to a correction, …

West Pharmaceutical Services (WST) has outperformed the S&P 500 by 21.8% over the past six … Medium (60%)

View full analysis →

Yahoo Finance 60% confidence